Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2021

MissionIRNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) Expands SEA Electric Partnership to Accelerate ‘BCS’ Development

Posted on February 9, 2021 by MissionIR

Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading clean technology company that has developed a new class of power electronics for electric motors and batteries, today announced that it has expanded its strategic partnership with SEA Electric Pty Ltd. (“SEA … Continue reading →

Posted in Exro Technologies Inc. EXROF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Forms Clinical Advisory Board, Announces $25M Registered Direct Offering

Posted on February 9, 2021 by MissionIR

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has announced that it has created a Clinical Advisory Board (“CAB”). The company has named world-renowned medical and clinical experts as the … Continue reading →

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Update on Platosa Project Exploration, Compelling Targets

Posted on February 9, 2021 by MissionIR

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today provided an update on ongoing exploration at the Platosa Project in Durango, Mexico, where four diamond drill rigs are currently active. “Exploration at Platosa continues to deliver compelling targets at … Continue reading →

Posted in Excellon Resources Inc. EXN | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters Collaboration for Planned Phase 2 Clinical Trial of FW-1022

Posted on February 9, 2021 by MissionIR

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced its entry into an agreement with PPD Inc. (NASDAQ: PPD ), a leading global contract research organization (“CRO”), … Continue reading →

Posted in MissionIRNewsBreaks, SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – SRAX (NASDAQ: SRAX) Announces LD Micro Index Reconstitution, Index Adds 423 Companies

Posted on February 9, 2021 by MissionIR

SRAX Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the reconstitution of its LD Micro Index. The announcement included impressive numbers that indicate the index’s … Continue reading →

Posted in MissionIRNewsBreaks, SRAX, Inc. SRAX | Leave a comment

SRAX Inc.’s (NASDAQ: SRAX) Sequire Provides Public Companies with Actionable Insights on Investor Activity While Severe Volatility Grips Markets

Posted on February 8, 2021 by MissionIR

Investor uncertainty rising as volatility continues to negatively affect stock market SRAX’s Sequire investor analytics platform provides actionable insights into investor behaviors for public companies Sequire has grown to 3 million+ active users across 90 public companies since 2019 Q3 … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is ‘One to Watch’

Posted on February 8, 2021 by MissionIR

Excellon’s portfolio currently includes active production at the Platosa Mine, with four additional assets in the development or exploration stages Excellon saw significant increases in production of lead, zinc and silver at the Platosa Mine from Q4 2019 to Q4 … Continue reading →

Posted in Excellon Resources Inc. EXN | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier

Posted on February 8, 2021 by MissionIR

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced its entry into a letter of intent to … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

Posted on February 8, 2021 by MissionIR

XPhyto Therapeutics Corp. is a life sciences technology accelerator involved in the development of new pharmaceuticals, diagnostic products and psychedelic investments XPhyto is preparing a series of clinical pilot studies for four drug candidates this year that could help in … Continue reading →

Posted in XPhyto Therapeutics Corp. XPHYF | Leave a comment

MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Collaboration with KLWTT to Offer Powerful Oracle CX Suite

Posted on February 8, 2021 by MissionIR

iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, is working with KLWTT (“KLWTT”) in a collaboration with Oracle to offer the Oracle Advertising and Customer Experience (“CX”) suite to their customers. A leading provider … Continue reading →

Posted in Small Cap News | Leave a comment